-
1
-
-
33845781654
-
Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis
-
Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF, Kullo IJ. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens. 2007 ; 20 (1). 83-89
-
(2007)
Am J Hypertens
, vol.20
, Issue.1
, pp. 83-89
-
-
Coutinho Tde, A.1
Turner, S.T.2
Peyser, P.A.3
Bielak, L.F.4
Sheedy, P.F.5
Kullo, I.J.6
-
2
-
-
33748477254
-
Elevated serum uric acid levels in metabolic syndrome: An active component or an innocent bystander
-
Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander. Metabolism. 2006 ; 55 (10). 1293-1301
-
(2006)
Metabolism
, vol.55
, Issue.10
, pp. 1293-1301
-
-
Tsouli, S.G.1
Liberopoulos, E.N.2
Mikhailidis, D.P.3
Athyros, V.G.4
Elisaf, M.S.5
-
3
-
-
0034898396
-
Effect of atorvastatin on serum uric acid levels
-
Kakafika A, Tsimihodimos V, Elisaf M. Effect of atorvastatin on serum uric acid levels. Atherosclerosis. 2001 ; 158 (1). 255
-
(2001)
Atherosclerosis
, vol.158
, Issue.1
, pp. 255
-
-
Kakafika, A.1
Tsimihodimos, V.2
Elisaf, M.3
-
4
-
-
5344244028
-
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia
-
Milionis HJ, Kakafika AI, Tsouli SG, et al. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004 ; 148 (4). 635-640
-
(2004)
Am Heart J
, vol.148
, Issue.4
, pp. 635-640
-
-
Milionis, H.J.1
Kakafika, A.I.2
Tsouli, S.G.3
-
5
-
-
0038637275
-
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia
-
Milionis HJ, Papakostas J, Kakafika A, Chasiotis G, Seferiadis K, Elisaf MS. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. J Clin Pharmacol. 2003 ; 43 (8). 825-830
-
(2003)
J Clin Pharmacol
, vol.43
, Issue.8
, pp. 825-830
-
-
Milionis, H.J.1
Papakostas, J.2
Kakafika, A.3
Chasiotis, G.4
Seferiadis, K.5
Elisaf, M.S.6
-
6
-
-
1542268611
-
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
-
Athyros VG, Elisaf M, Papageorgiou AA, et al. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart- disease Evaluation (GREACE) study. Am J Kidney Dis. 2004 ; 43 (4). 589-599
-
(2004)
Am J Kidney Dis
, vol.43
, Issue.4
, pp. 589-599
-
-
Athyros, V.G.1
Elisaf, M.2
Papageorgiou, A.A.3
-
7
-
-
33846023704
-
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study
-
Athyros VG, Mikhailidis DP, Liberopoulos EN, et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant. 2007 ; 22 (1). 118-127
-
(2007)
Nephrol Dial Transplant
, vol.22
, Issue.1
, pp. 118-127
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
Liberopoulos, E.N.3
-
8
-
-
77953702031
-
Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients
-
Ogata N, Fujimori S, Oka Y, Kaneko K. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients. Nucleosides Nucleotides Nucleic Acids. 2010 ; 29 (4-6). 321-324
-
(2010)
Nucleosides Nucleotides Nucleic Acids
, vol.29
, Issue.46
, pp. 321-324
-
-
Ogata, N.1
Fujimori, S.2
Oka, Y.3
Kaneko, K.4
-
9
-
-
0347093525
-
The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease
-
Youssef F, Gupta P, Seifalian AM, Myint F, Mikhailidis DP, Hamilton G. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology. 2004 ; 55 (1). 53-62
-
(2004)
Angiology
, vol.55
, Issue.1
, pp. 53-62
-
-
Youssef, F.1
Gupta, P.2
Seifalian, A.M.3
Myint, F.4
Mikhailidis, D.P.5
Hamilton, G.6
-
10
-
-
47949116865
-
The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia
-
Nakou ES, Filippatos TD, Georgoula M, et al. The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. Curr Med Res Opin. 2008 ; 24 (7). 1919-1929
-
(2008)
Curr Med Res Opin
, vol.24
, Issue.7
, pp. 1919-1929
-
-
Nakou, E.S.1
Filippatos, T.D.2
Georgoula, M.3
-
11
-
-
36048987346
-
Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin
-
Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Curr Med Res Opin. 2007 ; 23 (9). 2183-2192
-
(2007)
Curr Med Res Opin
, vol.23
, Issue.9
, pp. 2183-2192
-
-
Gazi, I.F.1
Daskalopoulou, S.S.2
Nair, D.R.3
Mikhailidis, D.P.4
-
12
-
-
80054712207
-
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance
-
Moutzouri E, Liberopoulos E, Mikhailidis DP, et al. Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance. Int J Clin Pract. 2011 ; 65 (11). 1141-1148
-
(2011)
Int J Clin Pract
, vol.65
, Issue.11
, pp. 1141-1148
-
-
Moutzouri, E.1
Liberopoulos, E.2
Mikhailidis, D.P.3
-
13
-
-
71749118226
-
-
Circulation. 2002: 3143-3421.
-
(2002)
Circulation
, pp. 3143-3421
-
-
-
14
-
-
10744221128
-
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
-
Hoieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004 ; 65 (3). 1041-1049
-
(2004)
Kidney Int
, vol.65
, Issue.3
, pp. 1041-1049
-
-
Hoieggen, A.1
Alderman, M.H.2
Kjeldsen, S.E.3
-
15
-
-
78649709694
-
Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study)
-
Brodov Y, Behar S, Boyko V, Chouraqui P. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). Am J Cardiol. 2010 ; 106 (12). 1717-1720
-
(2010)
Am J Cardiol
, vol.106
, Issue.12
, pp. 1717-1720
-
-
Brodov, Y.1
Behar, S.2
Boyko, V.3
Chouraqui, P.4
-
16
-
-
77950883722
-
Hypouricemic effect of statins: Another pleiotropic benefit?
-
Lopez-Cuenca A, Roldan V, Marin F. Hypouricemic effect of statins: another pleiotropic benefit?. J Thorac Cardiovasc Surg. 2010 ; 139 (5). 1358-1359
-
(2010)
J Thorac Cardiovasc Surg
, vol.139
, Issue.5
, pp. 1358-1359
-
-
Lopez-Cuenca, A.1
Roldan, V.2
Marin, F.3
-
17
-
-
79957778475
-
Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): The PATROL trial
-
Saku K, Zhang B, Noda K. Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial. Circ J. 2011 ; 75 (6). 1493-1505
-
(2011)
Circ J
, vol.75
, Issue.6
, pp. 1493-1505
-
-
Saku, K.1
Zhang, B.2
Noda, K.3
-
18
-
-
79960430739
-
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study
-
Athyros VG, Karagiannis A, Ganotakis ES, et al. Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin. 2011 ; 27 (8). 1659-1668
-
(2011)
Curr Med Res Opin
, vol.27
, Issue.8
, pp. 1659-1668
-
-
Athyros, V.G.1
Karagiannis, A.2
Ganotakis, E.S.3
-
19
-
-
33745714077
-
Treating to target patients with primary hyperlipidaemia: Comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)
-
Milionis HJ, Rizos E, Kostapanos M, et al. Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study). Curr Med Res Opin. 2006 ; 22 (6). 1123-1131
-
(2006)
Curr Med Res Opin
, vol.22
, Issue.6
, pp. 1123-1131
-
-
Milionis, H.J.1
Rizos, E.2
Kostapanos, M.3
-
20
-
-
23744441488
-
Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome
-
Yoo TW, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005 ; 69 (8). 928-933
-
(2005)
Circ J
, vol.69
, Issue.8
, pp. 928-933
-
-
Yoo, T.W.1
Sung, K.C.2
Shin, H.S.3
-
22
-
-
80052647784
-
Do HMG-CoA reductase inhibitors improve kidney function the saga continues
-
Campese VM, Ku E, Bigazzi R, Bianchi S. Do HMG-CoA reductase inhibitors improve kidney function The saga continues. J Nephrol. 2011 ; 24 (5). 550-553
-
(2011)
J Nephrol
, vol.24
, Issue.5
, pp. 550-553
-
-
Campese, V.M.1
Ku, E.2
Bigazzi, R.3
Bianchi, S.4
-
23
-
-
38449119409
-
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study
-
Shepherd J, Kastelein JJ, Bittner V, et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007 ; 2 (6). 1131-1139
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, Issue.6
, pp. 1131-1139
-
-
Shepherd, J.1
Kastelein, J.J.2
Bittner, V.3
-
24
-
-
77949332406
-
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial
-
Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol. 2010 ; 55 (12). 1266-1273
-
(2010)
J Am Coll Cardiol
, vol.55
, Issue.12
, pp. 1266-1273
-
-
Ridker, P.M.1
MacFadyen, J.2
Cressman, M.3
Glynn, R.J.4
-
25
-
-
33749866051
-
Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia
-
Kostapanos MS, Milionis HJ, Gazi I, Kostara C, Bairaktari ET, Elisaf M. Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia. J Clin Pharmacol. 2006 ; 46 (11). 1337-1343
-
(2006)
J Clin Pharmacol
, vol.46
, Issue.11
, pp. 1337-1343
-
-
Kostapanos, M.S.1
Milionis, H.J.2
Gazi, I.3
Kostara, C.4
Bairaktari, E.T.5
Elisaf, M.6
-
26
-
-
43049116177
-
The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans
-
Ky B, Burke A, Tsimikas S, et al. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. J Am Coll Cardiol. 2008 ; 51 (17). 1653-1662
-
(2008)
J Am Coll Cardiol
, vol.51
, Issue.17
, pp. 1653-1662
-
-
Ky, B.1
Burke, A.2
Tsimikas, S.3
-
27
-
-
70349331942
-
Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner
-
Nakamura T, Sato E, Fujiwara N, et al. Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner. Pharmacol Res. 2009 ; 60 (6). 525-528
-
(2009)
Pharmacol Res
, vol.60
, Issue.6
, pp. 525-528
-
-
Nakamura, T.1
Sato, E.2
Fujiwara, N.3
-
28
-
-
44449096625
-
Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: A pilot study
-
Turk TR, Voropaeva E, Kohnle M, et al. Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study. Nephrol Dial Transplant. 2008 ; 23 (1). 369-373
-
(2008)
Nephrol Dial Transplant
, vol.23
, Issue.1
, pp. 369-373
-
-
Turk, T.R.1
Voropaeva, E.2
Kohnle, M.3
-
29
-
-
70349335686
-
Clinical experience with ezetimibe/simvastatin in a Mediterranean population
-
Migdalis I, Efthimiadis A, Pappas S, Alexopoulos D, Vlasserou F, Mikhailidis DP. Clinical experience with ezetimibe/simvastatin in a Mediterranean population. Curr Med Res Opin. 2009 ; 25 (10). 2571-2576
-
(2009)
Curr Med Res Opin
, vol.25
, Issue.10
, pp. 2571-2576
-
-
Migdalis, I.1
Efthimiadis, A.2
Pappas, S.3
Alexopoulos, D.4
Vlasserou, F.5
Mikhailidis, D.P.6
|